KPI-121 0.25%

KPI-121 0.25%

WALTHAM, Mass.–(BUSINESS WIRE)–Dec. 26, 2018– Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics…

Read More